
Blood and urine markers may reveal ultra-processed food intake
Molecules in blood and urine may reveal how much energy a person consumes from ultra-processed foods, a key step to understanding their health impact, a new study has found.
It's the first time that scientists have identified biological markers that can indicate higher or lower intake of the foods, which are linked to a host of health problems, said Erikka Loftfield, a researcher at the National Cancer Institute in the United States who led the study published Tuesday in the journal PLOS Medicine.
"It can potentially give us some clues as to what the underlying biology might be between an ultra-processed food association and a health outcome," Loftfield said.
Ultra-processed foods – sugary cereals, sodas, crisps, frozen pizzas, and more – are created through industrial processes with ingredients such as additives, colours, and preservatives not found in home kitchens.
They're ubiquitous in high-income countries, but studying their health impacts is hard because it's difficult to accurately track what people eat.
For the new analysis, Loftfield and her colleagues examined data from an existing study of more than 1,000 older US adults. More than 700 of them had provided blood and urine samples, as well as detailed dietary recall reports, collected over a year.
The scientists found that hundreds of metabolites – products of digestion and other processes – corresponded to the percentage of energy a person consumes from ultra-processed foods.
From those, they devised a score of 28 blood markers and up to 33 urine markers that reliably predicted ultra-processed food intake in people who had typical diets.
"We found this signature that was sort of predictive of this dietary pattern that's high in ultra-processed food and not just a specific food item here and there," she said.
A few of the markers, notably two amino acids and a carbohydrate, showed up at least 60 times out of 100 testing iterations. One marker showed a potential link between a diet high in ultra-processed foods and type 2 diabetes, the study found.
It's still early research, but identifying blood and urine markers to predict ultra-processed foods consumption is "a major scientific advance," said Dr Dariush Mozaffarian, who directs the Food Is Medicine Institute at Tufts University in the US and was not involved in the study.
"With more research, these metabolic signatures can begin to untangle the biologic pathways and harms of UPF and also differences in health effects of specific UPF food groups, processing methods, and additives," he said.
Loftfield said she hopes to apply the tool to existing studies where blood and urine samples are available to track, for instance, the effect of consuming ultra-processed foods on cancer risk.
"There's a lot of interest across the board – scientifically, public interest, political interest – in the question of: Does ultra-processed food impact health and, if so, how?" she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Euronews
21-05-2025
- Euronews
Blood and urine markers may reveal ultra-processed food intake
Molecules in blood and urine may reveal how much energy a person consumes from ultra-processed foods, a key step to understanding their health impact, a new study has found. It's the first time that scientists have identified biological markers that can indicate higher or lower intake of the foods, which are linked to a host of health problems, said Erikka Loftfield, a researcher at the National Cancer Institute in the United States who led the study published Tuesday in the journal PLOS Medicine. "It can potentially give us some clues as to what the underlying biology might be between an ultra-processed food association and a health outcome," Loftfield said. Ultra-processed foods – sugary cereals, sodas, crisps, frozen pizzas, and more – are created through industrial processes with ingredients such as additives, colours, and preservatives not found in home kitchens. They're ubiquitous in high-income countries, but studying their health impacts is hard because it's difficult to accurately track what people eat. For the new analysis, Loftfield and her colleagues examined data from an existing study of more than 1,000 older US adults. More than 700 of them had provided blood and urine samples, as well as detailed dietary recall reports, collected over a year. The scientists found that hundreds of metabolites – products of digestion and other processes – corresponded to the percentage of energy a person consumes from ultra-processed foods. From those, they devised a score of 28 blood markers and up to 33 urine markers that reliably predicted ultra-processed food intake in people who had typical diets. "We found this signature that was sort of predictive of this dietary pattern that's high in ultra-processed food and not just a specific food item here and there," she said. A few of the markers, notably two amino acids and a carbohydrate, showed up at least 60 times out of 100 testing iterations. One marker showed a potential link between a diet high in ultra-processed foods and type 2 diabetes, the study found. It's still early research, but identifying blood and urine markers to predict ultra-processed foods consumption is "a major scientific advance," said Dr Dariush Mozaffarian, who directs the Food Is Medicine Institute at Tufts University in the US and was not involved in the study. "With more research, these metabolic signatures can begin to untangle the biologic pathways and harms of UPF and also differences in health effects of specific UPF food groups, processing methods, and additives," he said. Loftfield said she hopes to apply the tool to existing studies where blood and urine samples are available to track, for instance, the effect of consuming ultra-processed foods on cancer risk. "There's a lot of interest across the board – scientifically, public interest, political interest – in the question of: Does ultra-processed food impact health and, if so, how?" she said.


France 24
13-05-2025
- France 24
Trump slashed US cancer research by 31 percent: Senate report
The analysis, commissioned by the leftwing Senator Bernie Sanders, found that as of April, at least $13.5 billion in health funding had been terminated, including 1,660 grants, while thousands of scientific staff were fired. Among the hardest hit was the National Cancer Institute, which lost $2.7 billion from January to March compared to 2024, driving inflation-adjusted grant funding to its lowest level in over a decade. "Since January, Trump has launched an unprecedented, illegal and outrageous attack on science and scientists," said Sanders, the ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. "Trump is not only denying scientific truth but actively seeking to undermine it." Based on interviews with dozens of federal scientists and health workers, the report paints a picture of chaos across the Department of Health and Human Services (HHS), led by vaccine-skeptic Robert F. Kennedy Jr. At the Centers for Disease Control and Prevention (CDC), at least 175 public health datasets were deleted, leaving doctors "without vetted guidance on how to treat patients," one physician said. A 43-year-old colorectal cancer patient, already treated with surgery, radiation, and 48 rounds of chemotherapy, said her participation in a T-cell therapy trial at the NIH was delayed due to staff shortages. "The reality is that by reducing money and staff, the NIH will not be able to produce my treatment -- and it might cost me my life," she told Senate staff. At the NIH Clinical Center, researchers described "complete chaos" after entire labs were dismissed. "This administration has a lot of blood on their hands," said one. "We just want to take care of people." The report also highlighted the dangers of misinformation amid a growing measles outbreak, which has infected more than 1,000 people and killed three. Over 40 grants studying vaccine hesitancy have been canceled. Meanwhile, Kennedy has hired vaccine conspiracy theorist David Geier, previously disciplined for practicing medicine without a license and testing unproven drugs on autistic children, to investigate an alleged connection between vaccines and autism, debunked by dozens of prior studies. Even as Trump proposes a 26 percent cut to the HHS budget next year, he has earmarked $500 million for Kennedy's "Make America Healthy Again" initiative, which targets nutrition, physical activity, and "over-reliance on medication."


Euronews
09-05-2025
- Euronews
Which cancers are rising among people under age 50?
Cancer before the age of 50 is rare but increasing, and researchers want to know why. A new US government study provides the most complete picture yet of early-onset cancers, finding that the largest increases are in breast, colorectal, kidney, and uterine cancers. Scientists looked at data that included more than two million cancers diagnosed in people ages 15 to 49 between 2010 and 2019 in the US. Of 33 cancer types, 14 cancers had increasing rates in at least one younger age group. About 63 per cent of the early-onset cancers were among women, according to the study published on Thursday in the journal Cancer Discovery. "These kinds of patterns generally reflect something profound going on," said Tim Rebbeck of the US-based Dana-Farber Cancer Institute, who studies cancer risk and was not involved in the research. "We need to fund research that will help us understand". The researchers compared cancer rates in 2019 to what would be expected based on 2010 rates. Breast cancer made up the largest share of the excess cancers, with about 4,800 additional cases. Meanwhile, there were 2,000 more colorectal cancers, 1,800 more kidney cancers, and 1,200 additional uterine cancers than would be expected. Reassuringly, death rates were not rising for most cancers in the young adult age groups, although increasing death rates were seen for colorectal, uterine, and testicular cancers. Explanations will take more research. The big databases used for the study don't include information on risk factors or access to care. Theories abound, and a big meeting is planned later this year to bring together experts in the area. "Several of these cancer types are known to be associated with excess body weight, and so one of the leading hypotheses is increasing rates of obesity," said lead author Meredith Shiels of the US' National Cancer Institute. Advances in cancer detection and changes in screening guidelines could be behind some early diagnoses. For breast cancer, the trend toward women having a first child at older ages is a possible explanation. Pregnancy and breastfeeding are known to reduce risk. This isn't happening across the board. Cancer rates in people under 50 are going down for more than a dozen types of cancer, with the largest declines in lung and prostate cancers. Cigarette smoking has been declining in the US for decades, which likely accounts for the drop in lung cancer among younger adults. The drop in prostate cancer is likely tied to updated guidelines discouraging routine PSA testing in younger men because of concerns about overtreatment. A medication to treat men's hair loss comes with a rare risk of suicidal thoughts, the European Union's drugs regulator has determined. The safety committee of the European Medicines Agency (EMA) said it reviewed 313 reports of suicidal ideation among people taking the drug finasteride, which can stimulate hair growth and prevent hair loss for men aged 18 to 41. Finasteride is sold in 1 mg tablets under brand names such as Propecia. Meanwhile, 5 mg tablets are used to treat prostate enlargement that can cause problems urinating. Most of the reports of suicidal thoughts came from people taking the 1 mg tablets, but 'the frequency of the side effect is unknown,' the EMA concluded. Finasteride – which already comes with warnings about mood changes, such as depression and suicidal ideation – will remain on the shelves because the safety committee concluded that its benefits outweigh its risks. But the 1 mg tablets will now come with a card that reminds people of the risks and advises them on how to handle side effects, which can also include decreased sex drive or erectile dysfunction, the EMA said. The agency said people who experience mood changes while taking finasteride 1 mg should stop taking it and seek medical advice. The warnings will also be added to the medicine dutasteride, which is another treatment for prostate enlargement. The EMA safety committee did not have evidence linking the drug to suicidal thoughts, but because dutasteride works the same way as finasteride, the information will be added as a precaution. The agency noted that there were only a few hundred reports of suicidal ideation among about 270 million patients taking finasteride and 82 million taking dutasteride.